Microbial Biotransformation to Obtain New Antifungals

Area of Science:

• Pharmaceutical Biotechnology
• Microbiology
• Green Chemistry

Background:

• Limited chemical diversity in current antifungal drugs restricts therapeutic options.
• There is an urgent need for innovative antifungal agents with novel mechanisms of action.
• Discovering new antifungal molecules with distinct mechanisms is time-consuming and resource-intensive.

Purpose of the Study:

• To explore the role of pharmaceutical biotechnology in discovering antifungal compounds.
• To highlight microbial biotransformation as a key strategy for antifungal drug discovery.
• To review advancements in biotransformation processes and their application in generating novel antifungals.

Main Methods:

• Review of literature on microbial biotransformation of natural products and existing molecules.
• Exploration of biocatalysis for molecular modifications.
• Discussion of methodological improvements in whole-cell and immobilized enzyme processes.
• Assessment of endophytic fungi and in silico methods for antimicrobial discovery.

Main Results:

• Microbial biotransformation can yield novel antifungal molecules from herbal medicines and food sources.
• Biocatalysis enables significant modifications of existing molecules to enhance antifungal properties.
• Advancements in biotransformation techniques improve efficiency and reduce environmental impact.
• Endophytic fungi and in silico approaches show promise for discovering new antimicrobials.

Conclusions:

• Pharmaceutical biotechnology, particularly microbial biotransformation, offers a promising avenue for developing new antifungal drugs.
• Green chemistry principles are integral to these biotransformation procedures, ensuring efficiency and sustainability.
• Integrating various biotechnological tools can accelerate the discovery of novel antifungal agents to combat resistance.